Group One Trading, L.P. Sarepta Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 52,555 shares of SRPT stock, worth $831,945. This represents 0.15% of its overall portfolio holdings.
Number of Shares
52,555
Previous 54,128
2.91%
Holding current value
$831,945
Previous $6.58 Million
49.04%
% of portfolio
0.15%
Previous 0.25%
Shares
26 transactions
Others Institutions Holding SRPT
# of Institutions
493Shares Held
89.6MCall Options Held
1.39MPut Options Held
1.11M-
Black Rock Inc. New York, NY10.3MShares$163 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$143 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$143 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$64.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$53.3 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.39B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...